Roivant Sciences (ROIV) Treasury Shares (2021 - 2026)
Roivant Sciences (ROIV) reported Treasury Shares of $270000.0 for Q1 2026, down 99.62% on a YoY basis from $71.3 million in Q1 2025, and down 99.62% quarter-over-quarter from $71.3 million in Q1 2025.
Roivant Sciences (ROIV) Treasury Shares (2021 - 2026) Analysis & Trends
Roivant Sciences has reported Treasury Shares for 6 years, with the latest figure at $270000.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares fell 99.62% year-over-year to $270000.0; the trailing twelve-month figure through Mar 2026 stood at $270000.0 (down 99.62% YoY), and the FY2026 full-year result was $270000.0, down 22.53% from the prior year.
- Treasury Shares for Q1 2026 stood at $270000.0, down from $71.3 million in the prior quarter.
- The five-year high for Treasury Shares was $71.3 million in Q2 2024, with the low at $270000.0 in Q1 2026.
- Historically, Treasury Shares has averaged $22.4 million across 5 years, with a median of $20.4 million in 2023.
- Annual changes were most pronounced in 2024 — Treasury Shares jumped 2387.32% — and 2026, when it sank 99.62%.
- Roivant Sciences' Treasury Shares stood at $22.2 million in 2022, then dropped by 17.73% to $18.2 million in 2023, then plunged by 96.1% to $710060.0 in 2024, then surged by 9934.52% to $71.3 million in 2025, then slumped by 99.62% to $270000.0 in 2026.
- The last three Treasury Shares figures came in at $270000.0 (Q1 2026), $71.3 million (Q1 2025), and $710060.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | 270,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 270,000.00 |
| Mar 31, 2026 | 270,000.00 |
| Mar 31, 2025 | 71.25 Mn |
| Mar 31, 2025 | 71.25 Mn |
| Dec 31, 2024 | 710,060.00 |
| Dec 31, 2024 | 710,060.00 |
| Sep 30, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 71.25 Mn |
| Jun 30, 2024 | 71.25 Mn |
| Mar 31, 2024 | 11.36 Mn |
| Mar 31, 2024 | 11.36 Mn |
| Dec 31, 2023 | 18.23 Mn |
| Dec 31, 2023 | 18.23 Mn |
| Sep 30, 2023 | 20.07 Mn |
| Sep 30, 2023 | 20.07 Mn |
| Jun 30, 2023 | 2.86 Mn |
| Jun 30, 2023 | 2.86 Mn |
| Mar 31, 2023 | 20.70 Mn |
| Mar 31, 2023 | 20.70 Mn |